These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 36272561)
1. Resolution of depression: antidepressant actions of resolvins. Deyama S; Kaneda K; Minami M Neurosci Res; 2022 Oct; ():. PubMed ID: 36272561 [TBL] [Abstract][Full Text] [Related]
2. Resolvins as potential candidates for the treatment of major depressive disorder. Deyama S; Minami M; Kaneda K J Pharmacol Sci; 2021 Sep; 147(1):33-39. PubMed ID: 34294370 [TBL] [Abstract][Full Text] [Related]
3. [Resolvin E1 as a potential lead for the treatment of depression]. Deyama S; Minami M; Kaneda K Nihon Yakurigaku Zasshi; 2024; 159(4):210-213. PubMed ID: 38945902 [TBL] [Abstract][Full Text] [Related]
4. [Elucidation of the Mechanisms Underlying the Rapid Antidepressant Actions of Ketamine and Search for Possible Candidates for Novel Rapid-acting Antidepressants]. Deyama S Yakugaku Zasshi; 2023; 143(9):713-720. PubMed ID: 37661437 [TBL] [Abstract][Full Text] [Related]
5. [Resolvins as novel targets for rapid-acting antidepressants]. Deyama S Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254 [TBL] [Abstract][Full Text] [Related]
7. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex. Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634 [TBL] [Abstract][Full Text] [Related]
8. Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model. Ishikawa Y; Deyama S; Shimoda K; Yoshikawa K; Ide S; Satoh M; Minami M Behav Brain Res; 2017 Aug; 332():233-236. PubMed ID: 28610917 [TBL] [Abstract][Full Text] [Related]
9. The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice. Aoki S; Deyama S; Sugie R; Ishimura K; Fukuda H; Shuto S; Minami M; Kaneda K Behav Brain Res; 2022 Feb; 418():113676. PubMed ID: 34801580 [TBL] [Abstract][Full Text] [Related]
10. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Serhan CN; Libreros S; Nshimiyimana R Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568 [TBL] [Abstract][Full Text] [Related]
11. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045 [TBL] [Abstract][Full Text] [Related]
12. Formation of lipoxins and resolvins in human leukocytes. Kahnt AS; Schebb NH; Steinhilber D Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381 [TBL] [Abstract][Full Text] [Related]
13. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199 [TBL] [Abstract][Full Text] [Related]
14. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Serhan CN; Arita M; Hong S; Gotlinger K Lipids; 2004 Nov; 39(11):1125-32. PubMed ID: 15726828 [TBL] [Abstract][Full Text] [Related]
16. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. Oh SF; Pillai PS; Recchiuti A; Yang R; Serhan CN J Clin Invest; 2011 Feb; 121(2):569-81. PubMed ID: 21206090 [TBL] [Abstract][Full Text] [Related]
17. PRO-RESOLUTION POTENCY OF RESOLVINS D1, D2 AND E1 ON NEUTROPHIL MIGRATION AND IN DERMAL WOUND HEALING. Menon R; Krzyszczyk P; Berthiaume F Nano Life; 2017 Mar; 7(1):. PubMed ID: 29552232 [TBL] [Abstract][Full Text] [Related]
18. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Serhan CN; Gotlinger K; Hong S; Arita M Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791 [TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. Deyama S; Ishikawa Y; Yoshikawa K; Shimoda K; Ide S; Satoh M; Minami M Int J Neuropsychopharmacol; 2017 Jul; 20(7):575-584. PubMed ID: 28419244 [TBL] [Abstract][Full Text] [Related]
20. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Barden AE; Moghaddami M; Mas E; Phillips M; Cleland LG; Mori TA Prostaglandins Leukot Essent Fatty Acids; 2016 Apr; 107():24-9. PubMed ID: 27033423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]